Drug industry disaster concerns prompted lab expansion says Intertek


Drug industry concerns about natural disasters are driving demand for ‘storage-only’ stability testing according to Intertek, which has announced plans to increase capacity at its UK testing lab.

Avoca CEO Patricia Leuchten on stage at the Avoca Quality Consortium (AQC) summit.

Pace of change in clinical trial landscape has become rapid, says Avoca CEO

Evotec and Bayer formed a strategic alliance in October 2012. (Image: iStock/AlexeyVS)

Evotec reaches pre-clinical milestone in Bayer alliance

The First-in-Human trial demonstrated that the novel challenge agent had high attack rates of up to 100%. (Image: iStock/bodym)

SGS completes Ph I trial of new influenza virus


EMA proposal concerns: “Public health trumps commercial confidentiality”

(Image: iStock/Georgejason)

CRO partners with humanized model developer to advance liver disease research

Charles River has expanded its oncology discovery business. (Image: iStock/unoL)

Charles River partners with CRO to expand PDX model capabilities

CRO turnover increased from 20.1% in 2015 to 22% last year. (Image: iStock/PhotoProdra)

Report: CRO turnover creates loss of continuity

(Image: iStock/DigtialStorm)

Acurian: new consulting service provides 'continuum of support'

(Image: PPD)

PPD ups capacity at vaccine development lab

See More headlines